company background image
688293 logo

Shanghai OPM Biosciences SHSE:688293 Stock Report

Last Price

CN¥30.00

Market Cap

CN¥3.3b

7D

7.9%

1Y

-33.2%

Updated

22 Jul, 2024

Data

Company Financials +

Shanghai OPM Biosciences Co., Ltd.

SHSE:688293 Stock Report

Market Cap: CN¥3.3b

Shanghai OPM Biosciences Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai OPM Biosciences
Historical stock prices
Current Share PriceCN¥30.00
52 Week HighCN¥64.64
52 Week LowCN¥26.30
Beta0
11 Month Change-15.68%
3 Month Change-3.54%
1 Year Change-33.17%
33 Year Changen/a
5 Year Changen/a
Change since IPO-66.99%

Recent News & Updates

Shanghai OPM Biosciences' (SHSE:688293) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 06
Shanghai OPM Biosciences' (SHSE:688293) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

Shanghai OPM Biosciences' (SHSE:688293) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 06
Shanghai OPM Biosciences' (SHSE:688293) Weak Earnings May Only Reveal A Part Of The Whole Picture

Optimistic Investors Push Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Shares Up 28% But Growth Is Lacking

Mar 04
Optimistic Investors Push Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Shares Up 28% But Growth Is Lacking

Shareholder Returns

688293CN BiotechsCN Market
7D7.9%2.3%0.2%
1Y-33.2%-21.1%-16.6%

Return vs Industry: 688293 underperformed the CN Biotechs industry which returned -21.1% over the past year.

Return vs Market: 688293 underperformed the CN Market which returned -16.6% over the past year.

Price Volatility

Is 688293's price volatile compared to industry and market?
688293 volatility
688293 Average Weekly Movement7.1%
Biotechs Industry Average Movement6.1%
Market Average Movement5.9%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 688293's share price has been volatile over the past 3 months.

Volatility Over Time: 688293's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013285Zhihua Xiaowww.opmbio.com

Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers OPM cell culture media services, including OPM-CHO platform, OPM-293 platform, OPM-VAC platform, OPM-Hybri platform, and classical media; customized media solutions; and OEM media manufacturing services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development & cell banking platform, upstream process development, downstream process development, OPM formulation development platform, quality control and product characterization of biologics, and pilot scale production services.

Shanghai OPM Biosciences Co., Ltd. Fundamentals Summary

How do Shanghai OPM Biosciences's earnings and revenue compare to its market cap?
688293 fundamental statistics
Market capCN¥3.34b
Earnings (TTM)CN¥49.43m
Revenue (TTM)CN¥254.91m

69.1x

P/E Ratio

13.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688293 income statement (TTM)
RevenueCN¥254.91m
Cost of RevenueCN¥105.15m
Gross ProfitCN¥149.76m
Other ExpensesCN¥100.33m
EarningsCN¥49.43m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 27, 2024

Earnings per share (EPS)0.43
Gross Margin58.75%
Net Profit Margin19.39%
Debt/Equity Ratio0%

How did 688293 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

102%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.